Regulatory & Legal

The French biopharma giant posts strong 2025 results and forecasts over 13% growth, fueled by a booming pipeline and unexpected market advantages.

A potential first therapy for Charcot-Marie-Tooth disease heads to a major conference, showing promising functional gains despite missing its primary goal.

A new report shows 40% of ANZ firms never assess skin cancer risk, despite 84% seeing it as a duty of care, exposing a massive legal and health liability.

Proem Acquisition Corp I launches a $130M IPO, led by tech IPO guru Imran Khan. But can it succeed in a revived, yet risk-laden, SPAC landscape?

The satellite firm unveils a complex debt shuffle and $1B capital raise, fueling its network vision while sending its stock tumbling on dilution fears.

The health tech firm posts strong revenue and positive EBITDA, but SEC filings and a falling stock price reveal a more complex and challenging road ahead.

As BJ’s prepares to report Q4 results, investors are watching if a pizza relaunch and new efficiencies can overcome industry-wide cost pressures.

A bipartisan federal investigation will scrutinize university and government responses to a historic surge in antisemitism on college campuses since Oct. 7.

Vynleads launches its Done With Diabetes app, using AI for daily support. But can it stand out in a crowded market and reverse its financial fortunes?

The Investment Company Institute is linking its industry to America's 250th birthday. Is it a genuine celebration or a strategic rebrand?

Maureen Keough takes the helm at Solstice Environmental, bringing diverse tech and energy expertise to steer the firm through a new era of strategic growth.

Facing a national crisis of long waits for autism diagnosis, a new free online tool from Catalight hopes to connect families with care in days, not months.

Moody's affirms the Estonian energy giant's Baa3 rating, but a negative outlook signals deep-seated risks from its oil shale legacy and market volatility.

As Jonathan and Jason Morgan become co-CEOs, the multifamily giant eyes further growth with a new C-suite and a powerful capital deployment strategy.

With plastic film recycling rates below 1%, a new U.S. Plastics Pact framework offers a pragmatic plan to tackle one of recycling's toughest challenges.

A non-invasive device for spinal cord injury gains major international praise, signaling a shift in neurorehabilitation and a path to market.

A new partnership between Public and Level2 gives retail investors no-code tools to automate trading, but does this empowerment come with hidden risks?

A new partnership tackles the immense thermal challenge of AI, aiming to embed advanced cooling solutions from the ground up in Korea's data centers.

Energy giant Chevron enters Libya's oil sector, a move balancing immense potential against deep-seated political instability and environmental risks.

With its Q4 and full-year 2025 earnings release imminent, Ingevity faces investor scrutiny over its recent strategic divestitures and market position.